These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 17064755)

  • 21. Time course of platelet aggregation during thrombolytic treatment of massive pulmonary embolism.
    Mühl D; Füredi R; Gecse K; Ghosh S; Falusi B; Bogár L; Roth E; Lantos J
    Blood Coagul Fibrinolysis; 2007 Oct; 18(7):661-7. PubMed ID: 17890954
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Electrochemical processing of fibrinogen modified-graphite surfaces: effect on plasmin generation from adsorbed plasminogen.
    Alfonsi-Hourdin S; Longchamp S; Gallet O; Nigretto JM
    Biomaterials; 2006 Jan; 27(1):52-60. PubMed ID: 16029886
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Plasminogen activator inhibitor type 2 inhibits cell surface associated tissue plasminogen activator in vitro: potential receptor interactions.
    Lobov S; Croucher DR; Saunders DN; Ranson M
    Thromb Haemost; 2008 Aug; 100(2):319-29. PubMed ID: 18690354
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Systemic administration of anti-urokinase plasminogen activator receptor monoclonal antibodies induces hepatic fibrin deposition in tissue-type plasminogen activator deficient mice.
    Jögi A; Pass J; Høyer-Hansen G; Lund LR; Nielsen BS; Danø K; Rømer J
    J Thromb Haemost; 2007 Sep; 5(9):1936-44. PubMed ID: 17723133
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Fibrinolytic system in normotensive subjects and hypertensive patients.
    Armas-Hernández MJ; Hernández-Hernández R; Armas-Padilla MC; Sosa-Canache B; Cammarata R; Pacheco B; Guerrero-Pajuelo J; Israili ZH; Valasco M
    Am J Ther; 2007; 14(2):177-82. PubMed ID: 17414587
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Desmoteplase in acute massive pulmonary thromboembolism.
    Tebbe U; Bramlage P; Graf A; Lechleitner P; Bode C; Riess FC; Clemens N; Al-Rawi Y; Konstantinides S; Goldhaber SZ
    Thromb Haemost; 2009 Mar; 101(3):557-62. PubMed ID: 19277420
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Plasmin in human blood plasma].
    Beremeenko KN; Volokhonskaia LI; Kizim AI; Khomenko LA; Groma SP
    Ukr Biokhim Zh (1978); 1978; 50(4):475-9. PubMed ID: 150669
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparison of blood viscosity using a torsional oscillation viscometer and a rheometer.
    Travagli V; Zanardi I; Boschi L; Gabbrielli A; Mastronuzzi VA; Cappelli R; Forconi S
    Clin Hemorheol Microcirc; 2008; 38(2):65-74. PubMed ID: 18198407
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Discreplasminin, a plasmin inhibitor isolated from Tityus discrepans scorpion venom.
    Brazón J; D'Suze G; D'Errico ML; Arocha-Piñango CL; Guerrero B
    Arch Toxicol; 2009 Jul; 83(7):669-78. PubMed ID: 19015833
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Novel distribution pattern of fibrinolytic components in rabbit tissues extract: a preliminary study.
    Lu XG; Wu XG; Xu XH; Gong XB; Zhou X; Xu GB; Zhu L; Zhao XY
    J Zhejiang Univ Sci B; 2007 Aug; 8(8):570-4. PubMed ID: 17657859
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Simplified recombinant plasmin: production and functional comparison of a novel thrombolytic molecule with plasma-derived plasmin.
    Hunt JA; Petteway SR; Scuderi P; Novokhatny V
    Thromb Haemost; 2008 Sep; 100(3):413-9. PubMed ID: 18766256
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A collaborative study to establish the 3rd International Standard for tissue plasminogen activator.
    Sands D; Whitton CM; Merton RE; Longstaff C
    Thromb Haemost; 2002 Aug; 88(2):294-7. PubMed ID: 12195703
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Effects of Tianma Xingnao capsule on thrombosis and coagulation system].
    Yang J; He B; Yang Y; Zhan X; Zhen J; Shen Z
    Zhongguo Zhong Yao Za Zhi; 2009 Mar; 34(6):756-60. PubMed ID: 19624023
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Multiple interactions of FbsA, a surface protein from Streptococcus agalactiae, with fibrinogen: affinity, stoichiometry, and structural characterization.
    Pietrocola G; Visai L; Valtulina V; Vignati E; Rindi S; Arciola CR; Piazza R; Speziale P
    Biochemistry; 2006 Oct; 45(42):12840-52. PubMed ID: 17042502
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Kinetic parameters for plasminogen activation by tissue type plasminogen activator.
    Machovich R
    Thromb Haemost; 1997 May; 77(5):1041-2. PubMed ID: 9184430
    [No Abstract]   [Full Text] [Related]  

  • 36. Effect of ACE inhibition on the fibrinolytic system in patients requiring coronary artery bypass grafting.
    Walter T; Szabo S; Kazmaier S; Suselbeck T; Borggrefe M; Hoffmeister HM
    Thorac Cardiovasc Surg; 2009 Sep; 57(6):368-71. PubMed ID: 19707983
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Probing the beta-chain hole of fibrinogen with synthetic peptides that differ at their amino termini.
    Doolittle RF; Pandi L
    Biochemistry; 2007 Sep; 46(35):10033-8. PubMed ID: 17688324
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Changes in fibrinolytic activity of blood after prostatectomy.
    Udayashanker B
    Indian J Physiol Pharmacol; 2000 Oct; 44(4):485-90. PubMed ID: 11214506
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Dysfibrinogen Kagoshima with the amino acid substitution gammaThr-314 to Ile: analyses of molecular abnormalities and thrombophilic nature of this abnormal molecule.
    Niwa K; Mimuro J; Miyata M; Sugo T; Ohmori T; Madoiwa S; Tei C; Sakata Y
    Thromb Res; 2008; 121(6):773-80. PubMed ID: 17854865
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Platelet (dys)function and plasma plasminogen levels in hemodialysis patients.
    Salobir B; Sabovic M; Zupan IP; Ponikvar JB
    Ther Apher Dial; 2008 Apr; 12(2):133-6. PubMed ID: 18387161
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.